Sandbox: Shamila: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{ | {{Mixed connective tissue disease}} | ||
{{ | {{SI}} | ||
{{ | {{CMG}}; {{AE}} {{CZ}}, {{JH}}, {{MIR}} | ||
{{ | |||
{{ | {{SK}} MCTD; mixed connective tissue disorder; Sharp's syndrome | ||
==Overview== | |||
'''Mixed connective tissue disease''' ('''MCTD''') or ''Sharp's syndrome'' is a human [[autoimmune disease]] in which the [[immune system]] attacks the body. MCTD combines features of [[polymyositis]], [[systemic lupus erythematosus]], and [[systemic scleroderma]] and is thus considered an [[overlap syndrome]]. MCTD commonly causes [[arthritis|joint pain/swelling]], [[Raynaud phenomenon]], [[myositis|muscle inflammation]], and [[sclerodactyly|scarring of the skin of the hand]]. It does not typically cause [[kidney]] disease or [[seizure]]s. Distinguishing laboratory characteristics are a positive, speckled [[anti-nuclear antibody]] and an [[anti-U1-RNP antibody]].<ref>Venables PJ. ''Mixed connective tissue disease.'' Lupus. 2006;15(3):132-7. PMID 1663436</ref> | |||
==Pathophysiology== | |||
There are no specific histologic findings that aid in the diagnosis of [[Mixed Connective Tissue Disorder]] as a separate autoimmune disease. For example, [[nephritis]] in [[MCTD]] is usually indistinguishable from [[lupus]] nephritis. | |||
<div align="left"> | |||
<gallery heights="225" widths="225"> | |||
image:Fibrous Pericarditis in MCTD.jpg|Fibrous Pericarditis in MCTD | |||
image:Cellular aggregates in perivascular space and adjacent myocardium.jpg|Cellular aggregates in perivascular space and adjacent myocardium | |||
image:Cross Section of Intramural Coronary Artery.jpg|Cross Section of Intramural Coronary Artery | |||
image:Small pulmonary artery in patient with MCTD and pulmonary hypertension.jpg|Small pulmonary artery in patient with MCTD and pulmnonary hypertension | |||
</gallery> | |||
</div> | |||
==Historical Perspective== | |||
==Classification== | |||
==Pathophysiology== | |||
*Associated Conditions: | |||
**[[Systemic lupus erythematosus]]–like findings | |||
***[[Polyarthritis]] | |||
***[[Lymphadenopathy]] | |||
***Facial [[erythema]] | |||
***[[Pericarditis]] or [[pleuritis]] | |||
***[[Leukopenia]] (<4,000/mm3) or thrombocytopenia (<100,000/mm3) | |||
**[[Scleroderma|Progressive Systemic Sclerosis]] –like findings | |||
***[[Sclerodactyly]] | |||
***[[Pulmonary fibrosis]], restrictive changes of the lung (forced vital capacity <80% of predicted), or reduced carbon monoxide diffusing capacity (<70% of predicted) | |||
**[[Polymyositis]]-like findings | |||
==Causes== | |||
==Differentiating Mixed Connective Tissue Disease from other Diseases== | |||
==Epidemiology and Demographics== | |||
===Age=== | |||
===Gender=== | |||
===Race=== | |||
==Risk Factors== | |||
==Natural History, Complications and Prognosis== | |||
Cardiovascular abnormalities associated with mixed connective tissue disease are rare. Presence of any of the complications listed below indicates unfavorable prognosis; | |||
*Acute [[pericarditis]] and/or [[pericardial effusion]], | |||
*[[Mitral valve prolapse]], | |||
*Intimal hyperplasia of coronary arteries, | |||
*Perivascular and myocardial leukocytic infiltrates, | |||
*[[Pulmonary hypertension]]. | |||
*Coronary Artery Disease (although it is rarer, ACS may occur secondary to vascular changes and underlying CAD. The youngest patient with MCTD and ACS in literature was 18 years old)<ref>Jang J J, Olin J W, Fuster V. A teenager with mixed connective tissue disease presenting with an acute coronary syndrome. Vascular Medicine; 2004, Vol. 9 Issue 1, 31-34</ref> | |||
<div align="left"> | |||
<gallery heights="225" widths="225"> | |||
image:Teenager before PCI.jpg|A teenager with MCTD presented as ACS before PCI | |||
image:Teenager post PCI.jpg|A teenager with MCTD presented as ACS post PCI | |||
</gallery> | |||
</div> | |||
==Diagnosis== | |||
===Diagnostic Criteria=== | |||
===Symptoms=== | |||
*[[Raynaud’s phenomenon]] | |||
*Swollen fingers or hands | |||
*Muscle weakness | |||
===Physical examination=== | |||
====Gallery==== | |||
=====Trunk===== | |||
<gallery> | |||
Image: Mixed_connective_tissue_disease_01.jpg|Mixed connective tissue disease. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=12 With permission from Dermatology Atlas.]''<ref name="www.atlasdermatologico.com.br">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=294> | |||
</gallery> | |||
=====Extremities===== | |||
<gallery> | |||
Image: Mixed_connective_tissue_disease_02.jpg|Mixed connective tissue disease. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=12 With permission from Dermatology Atlas.]''<ref name="www.atlasdermatologico.com.br">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=294> | |||
Image: Mixed_connective_tissue_disease_03.jpg|Mixed connective tissue disease. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=12 With permission from Dermatology Atlas.]''<ref name="www.atlasdermatologico.com.br">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=294> | |||
</gallery> | |||
===Laboratory Findings=== | |||
*Elevated serum level of muscle enzymes (creatine kinase) | |||
*MCTD is characterized by anti–U1 small nuclear RNP positivity. | |||
===Imaging Findings=== | |||
**Myogenic pattern on electromyogram | |||
===Other Diagnostic Studies=== | |||
**Hypomotility or dilatation of esophagus | |||
== References == | |||
{{reflist|2}} |
Revision as of 20:47, 26 March 2018
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Sandbox: Shamila On the Web |
American Roentgen Ray Society Images of Sandbox: Shamila |
Directions to Hospitals Treating Mixed connective tissue disease |
WikiDoc Resources for Sandbox: Shamila |
Articles |
---|
Most recent articles on Sandbox: Shamila Most cited articles on Sandbox: Shamila |
Media |
Powerpoint slides on Sandbox: Shamila |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Sandbox: Shamila at Clinical Trials.gov Trial results on Sandbox: Shamila Clinical Trials on Sandbox: Shamila at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Sandbox: Shamila NICE Guidance on Sandbox: Shamila
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Sandbox: Shamila Discussion groups on Sandbox: Shamila Patient Handouts on Sandbox: Shamila Directions to Hospitals Treating Sandbox: Shamila Risk calculators and risk factors for Sandbox: Shamila
|
Healthcare Provider Resources |
Causes & Risk Factors for Sandbox: Shamila |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Jesus Rosario Hernandez, M.D. [3], Mahshid Mir, M.D. [4]
Synonyms and keywords: MCTD; mixed connective tissue disorder; Sharp's syndrome
Overview
Mixed connective tissue disease (MCTD) or Sharp's syndrome is a human autoimmune disease in which the immune system attacks the body. MCTD combines features of polymyositis, systemic lupus erythematosus, and systemic scleroderma and is thus considered an overlap syndrome. MCTD commonly causes joint pain/swelling, Raynaud phenomenon, muscle inflammation, and scarring of the skin of the hand. It does not typically cause kidney disease or seizures. Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody.[1]
Pathophysiology
There are no specific histologic findings that aid in the diagnosis of Mixed Connective Tissue Disorder as a separate autoimmune disease. For example, nephritis in MCTD is usually indistinguishable from lupus nephritis.
-
Fibrous Pericarditis in MCTD
-
Cellular aggregates in perivascular space and adjacent myocardium
-
Cross Section of Intramural Coronary Artery
-
Small pulmonary artery in patient with MCTD and pulmnonary hypertension
Historical Perspective
Classification
Pathophysiology
- Associated Conditions:
- Systemic lupus erythematosus–like findings
- Polyarthritis
- Lymphadenopathy
- Facial erythema
- Pericarditis or pleuritis
- Leukopenia (<4,000/mm3) or thrombocytopenia (<100,000/mm3)
- Progressive Systemic Sclerosis –like findings
- Sclerodactyly
- Pulmonary fibrosis, restrictive changes of the lung (forced vital capacity <80% of predicted), or reduced carbon monoxide diffusing capacity (<70% of predicted)
- Polymyositis-like findings
- Systemic lupus erythematosus–like findings
Causes
Differentiating Mixed Connective Tissue Disease from other Diseases
Epidemiology and Demographics
Age
Gender
Race
Risk Factors
Natural History, Complications and Prognosis
Cardiovascular abnormalities associated with mixed connective tissue disease are rare. Presence of any of the complications listed below indicates unfavorable prognosis;
- Acute pericarditis and/or pericardial effusion,
- Mitral valve prolapse,
- Intimal hyperplasia of coronary arteries,
- Perivascular and myocardial leukocytic infiltrates,
- Pulmonary hypertension.
- Coronary Artery Disease (although it is rarer, ACS may occur secondary to vascular changes and underlying CAD. The youngest patient with MCTD and ACS in literature was 18 years old)[2]
Diagnosis
Diagnostic Criteria
Symptoms
- Raynaud’s phenomenon
- Swollen fingers or hands
- Muscle weakness
Physical examination
Gallery
Trunk
Extremities
Laboratory Findings
- Elevated serum level of muscle enzymes (creatine kinase)
- MCTD is characterized by anti–U1 small nuclear RNP positivity.
Imaging Findings
- Myogenic pattern on electromyogram
Other Diagnostic Studies
- Hypomotility or dilatation of esophagus